Literature DB >> 15086212

Surgical treatment for serous cystadenoma of pancreas--segmental pancreatectomy or conventional resection?

Cheng-Hsi Su1, Yi-Ming Shyr, Wing-Yiu Lui, Fang-Ku P'eng.   

Abstract

BACKGROUND/AIMS: Benign tumors located in the neck or body of the pancreas are usually removed by left pancreatectomy or pancreaticoduodenectomy when enucleation is too risky for possible damage of the main pancreatic duct. But standard pancreatic resection has its potential operative risk and may result in loss of pancreatic parenchyme and cause impairment of pancreatic function. The aim of this study was to compare the results of segmental pancreatectomy, a limited resection of the mid-portion of the pancreas, and traditional extensive pancreatic resection, i.e. distal pancreatectomy or pancreaticoduodencetomy in patients with serous cystadenoma of the pancreas.
METHODOLOGY: From January 1989 to February 2002, 19 patients with serous cystadenoma of the pancreas treated with pancreatic resection were reviewed. Among them segmental pancreatectomy was performed in 5 cases, distal pancreatectomy was carried out in 11, pancreaticoduodenectomy in 2 and total pancreatectomy in one patient.
RESULTS: Operation time was significantly longer in segmental pancreatectomy than in distal pancreatectomy (P<0.001) and a greater blood loss was also noticed in the conventional resection. There was no operative mortality and the postoperative hospital stays were not different in any group. A higher rate of pancreatic fistula was encountered in segmental pancreatectomy, however all of the fistulas sealed off after conservative treatment. A trend of higher chance of developing postoperative diabetes was noticed in the conventional resection. Except for the patient who underwent total pancreatectomy no patient developed frank steatorrhea during long-term follow-up.
CONCLUSIONS: Segmental pancreatectomy is a safe and technically feasible procedure in selected patients with benign pancreatic tumor. This procedure carries a similar surgical risk as that of standard operation, but avoids extensive pancreatic resection which in turn may preserve more pancreatic functions.

Entities:  

Mesh:

Year:  2004        PMID: 15086212

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

Authors:  Cosimo Sperti; Valentina Beltrame; Anna Caterina Milanetto; Margherita Moro; Sergio Pedrazzoli
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

2.  Middle segmental pancreatectomy: a safe and organ-preserving option for benign and low-grade malignant lesions.

Authors:  Zhi-Yong Du; Shi Chen; Bao-San Han; Bai-Yong Shen; Ying-Bing Liu; Cheng-Hong Peng
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

3.  The Dagradi-Serio-Iacono operation central pancreatectomy.

Authors:  Calogero Iacono; Luca Bortolasi; Enrico Facci; Filippo Nifosì; Silvia Pachera; Andrea Ruzzenente; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

4.  Overall Postoperative Morbidity and Pancreatic Fistula Are Relatively Higher after Central Pancreatectomy than Distal Pancreatic Resection: A Systematic Review and Meta-Analysis.

Authors:  Parbatraj Regmi; Qing Yang; Hai-Jie Hu; Fei Liu; Hare Ram Karn; Wen-Jie Ma; Cong-Dun Ran; Fu-Yu Li
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.